Skip to main content

Table 2 Summary of HR for OS by Age

From: Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis

Age HR (95% CI)
Age < 65 years 0.68 (0.61 to 0.75)
Age ≥ 65 years 0.64 (0.54 to 0.76)